Biopharma giant Gilead Sciences will shut down its office in Seattle’s Eastlake neighborhood, the company confirmed to ...

Gilead Sciences (NASDAQ:GILD) reported positive results from a pivotal Phase 3 study of its twice-yearly HIV prevention ...

Citi initiated coverage of Gilead (GILD) with a Buy rating and $125 price target The firm says that despite the stock’s near-term ...

Despite a robust HIV portfolio and growing oncology sales, Gilead struggles to diversify revenue streams significantly. Learn ...

(RTTNews) - Gilead Sciences Inc. (GILD) announced the pricing of senior unsecured notes in an aggregate principal amount of $3.5 billion, in an underwritten, registered public offering, consisting of ...

Gilead Sciences ( GILD) increased its growth forecast for the year on strong third quarter results, marking a shift away from ...

(This story was updated to accurately reflect the most current information.) OBETZ — Mount Gilead left nothing to chance this ...

Developer Autolus set a list price of $525,000 for its new cell therapy, which it will sell for a type of leukemia under the ...

"The first question he asked was did the team win," Mount Gilead head coach Jake Hayes said of his now four-time All-Ohioan ...

Data shows Latino and Black people make up nearly 30% of the Bay Area population but only about 10% of active medical ...

OBETZ — Mount Gilead's boys cross country team has enjoyed a decade of dominance unlike any high school sports program in the Marion area. Saturday was another link in the chain when MG won the ...